Refresh
A replenishing ritual for skin that looks hydrated, rested and smoother.
GHK-Cu skin + scalp care · First edition
Precision,
in violet.
A refreshing copper-peptide ritual designed to leave skin looking smoother, firmer and rejuvenated, while helping hair look fuller and healthier.
Copper peptide skincareMade for skin + scalpIn development
01 / The ritual
The VIOLETIVA approach
Refresh skin. Reawaken the ritual.
VIOLETIVA brings a GHK-Cu copper peptide concentrate and a precision stamping applicator into one considered skin and scalp ritual.
Rejuvenate
Designed around the look of firmness, softened lines and a more even texture.
Revive
A considered scalp routine aimed at fuller, healthier-looking hair over time.
Clearly in development
These are product goals, not promised outcomes. Final formulation, device compatibility, safety and user testing come before release.
02 / The evidence
GHK-Cu + microneedling research
The science behind the idea.
Explore the most promising signals for copper peptide skincare, facial rejuvenation and hair density. Every source is clearly scoped and separate from VIOLETIVA.
Clinical signal · 8 weeks
The wrinkle data worth watching.
In a randomized, double-blind study, a nano-carrier GHK-Cu serum outperformed its controls on measured facial wrinkle volume and depth after eight weeks. GHK-Cu is a naturally occurring copper-binding tripeptide; laboratory research suggests it may support collagen and elastin production, extracellular-matrix renewal and inflammatory regulation.
Measured study outcomes
55.8%lower wrinkle volume vs control
32.8%lower wrinkle depth vs control
31.6%lower wrinkle volume vs comparator peptide
Promising, but formulation-specific, small and short-term. Thirty-nine women completed the study, which used nano-encapsulated GHK-Cu rather than VIOLETIVA. Results cannot be assumed for other formulas or delivery methods.
Read the 8-week studyVIOLETIVA evidence · next
Our product needs its own proof.
Formulation compatibility, stability and microbiological testing come first, followed by a controlled user study built around defined skin endpoints.
Study status · Not yet initiatedRegulatory context. The FDA has legally authorized only specific microneedling devices for specific uses. VIOLETIVA is in development, is not FDA-cleared, and has not been proven to regrow hair or deliver topical products into skin. The FDA has not cleared microneedling devices for hair loss or for use with topical products. FDA guidance ↗
03 / Private first release
Be first to meet VIOLETIVA.
Join the early list for development notes, first access and the story behind the first VIOLETIVA ritual.
Occasional launch notes. Nothing unnecessary. Privacy